News Industry News Amarin Reaffirms Its Mission to Improve Patient Care With Commitment to Completing REDUCE-IT Cardiovascular Outcomes Study September 16, 2014
News Industry News Amarin Announces Publication of Case Study Results Describing Reductions in Multiple Lipid Parameters for Individual Hyperlipidemic Patients Switched to Vascepa(R) June 11, 2014
News Industry News US FDA approves EPANOVA for the treatment of adults with severe hypertriglyceridaemia May 06, 2014
Presentation TCT 2013 Fish Oil and CHD Benefit: Is It the Dose, Type, Genetics or Blood Level? (EPA, DHA, FADS) Presenter: H. Robert Superko October 31, 2013
News Industry News Pivotal Therapeutics exhibiting at European Society of Cardiology Congress 2012 August 23, 2012